Elcam Medical New Generation Flexi-Q Auto-Injectors
Elcam Medical New Generation Flexi-Q Auto-Injectors Elcam Medical New Generation Flexi-Q Auto-Injectors
Testimonials – from recent work withpharma companies (cont.)Year /Company* Description Testimonials2010Smallmediumsize biotech2009One of top10 pharmaStage I: Few conceptdesigns and draftinga patent applicationfor the sameFeasibility project forthe use of one of theFlexi-Q PFSautoinjector for aPhase III drug“Very much satisfied from the work done; Well done!Awaiting for the next stage of feasibility”;R.L. , PhD, Patent Attorney, Director of Intellectual Property“The engineering analysis David provided wasexcellent. I would rate it on par with work we havecontracted in the past with ENGINEERING companieswho have ONLY THAT FOCUS AS THEIR BUSINESSSERVICE. “J.J., Senior Program Manager462008One of top10 biopharmacompaniesFeasibility project forthe use of one of theFlexi-Q DVautoinjector for aPhase II drug“… Regarding the new prototype of the Flexi-Qdevice, all of the people I have shown the device tohave been really pleased with the outcome.”“As always, you have provided an exceptionalamount of quality with your work. Thank you for allof your efforts.”C.B., PhD, Senior Biologic Project Manager, R&D* Due to confidentiality agreements, no disclosure of company names are possible
Summary: Elcam Medical• Elcam has a broad line of innovative solutions for easyto-useself-administration of drugs - all are customizableto meet your specific needs• Elcam has a long history being a reliable partner providinghigh quality and excellent service in the single-usedisposable fluid control products• Experience working with some major US pharma companiesin the fields of anemia, RA, MS, microspheres/high viscosity• Elcam is well positioned to provide you with its uniqueFlexi-Q line for current and future needs and assist in lifecyclemanagement47
- Page 1 and 2: Elcam MedicalNew GenerationFlexi-Q
- Page 3 and 4: Elcam’s Manufacturing Facilities
- Page 5 and 6: 5Elcam’s Major Customers
- Page 7 and 8: Novel, Commercially AvailableFlexi-
- Page 9 and 10: Flexi-Q DV Design Characteristics -
- Page 11 and 12: Vial Adaptor Options• Standard Vi
- Page 13 and 14: Yellow RodRed INJECTButtonGrip Area
- Page 15 and 16: 1. Remove the Safety Cover of theAu
- Page 17 and 18: 41. Gently Push the Yellow Rodall t
- Page 19 and 20: 61. Hold the Auto-injector vertical
- Page 21 and 22: 81. Tap near Dosage Window to movel
- Page 23 and 24: 101. Remove the Gray Connector bypr
- Page 25 and 26: 121. Hold the Auto-injector at the
- Page 27 and 28: • Discard the device according to
- Page 29 and 30: Device Validation• Simulated Clin
- Page 31 and 32: Study Results1. All users successfu
- Page 33 and 34: 33Flexi-Q P-DVR use by RA Patient:v
- Page 35 and 36: Background• Flexi-Q DV is assembl
- Page 37 and 38: Background (cont.)• In many cases
- Page 39 and 40: Method• Glass syringe, 3-bevel 27
- Page 41 and 42: Results & DiscussionTPE SeptumF 1 -
- Page 43 and 44: ConclusionsUsing the TPE Septum mat
- Page 45: Testimonials - from recent work wit
Testimonials – from recent work withpharma companies (cont.)Year /Company* Description Testimonials2010Smallmediumsize biotech2009One of top10 pharmaStage I: Few conceptdesigns and draftinga patent applicationfor the sameFeasibility project forthe use of one of the<strong>Flexi</strong>-Q PFSautoinjector for aPhase III drug“Very much satisfied from the work done; Well done!Awaiting for the next stage of feasibility”;R.L. , PhD, Patent Attorney, Director of Intellectual Property“The engineering analysis David provided wasexcellent. I would rate it on par with work we havecontracted in the past with ENGINEERING companieswho have ONLY THAT FOCUS AS THEIR BUSINESSSERVICE. “J.J., Senior Program Manager462008One of top10 biopharmacompaniesFeasibility project forthe use of one of the<strong>Flexi</strong>-Q DVautoinjector for aPhase II drug“… Regarding the new prototype of the <strong>Flexi</strong>-Qdevice, all of the people I have shown the device tohave been really pleased with the outcome.”“As always, you have provided an exceptionalamount of quality with your work. Thank you for allof your efforts.”C.B., PhD, Senior Biologic Project Manager, R&D* Due to confidentiality agreements, no disclosure of company names are possible
Change language